EMVision Medical Devices Ltd ASX:EMV FY26 Results Presentation August 2026 This Presentation has been prepared by EMVision Medical Devices Ltd (ACN 620 388 230) (the “Company”). This Presentation is for information purposes only and should be read in conjunction with the most recent...
FY26 Results Presentation
Filed with ASX ·
6ix hasn’t read this filing yet.
EMvision Medical Devices Ltd. on 6ix
In the deck
Story so far
Earlier from EMvision Medical Devices
- Appendix 4G & Corporate Governance Statement
- Change of Registered Office Address
- Aeromedical Study De-Risks Rural & Remote Stroke Use Cases
- EMVision to Receive $1.17M IGP Grant Instalment
- emu Pivotal Trial Expansion Adds Acute Ischaemia Detection
Later from EMvision Medical Devices
- Appendix 4E & Annual Report to 30 June 2026
- emu Pivotal Trial Recruitment Surpasses 200 Patients
- emu Regional Benefits Study Advancing
- Notification regarding unquoted securities - EMV
- First Responder Successfully Trialled with MSU
Follow EMvision Medical Devices into a list and get an email when it puts out news.
Follow EMvision Medical Devices